T CELL LYMPHOMA

Dr Reddy's may file two new drugs with FDA by 2019

"As of March 31, 2017, we had 16 active productdevelopment programs in our pipeline (for DFN-02- the drug totreat acute treatment of migraines, with or without aura inadults) Phase 3 is completed.